Lithium regulates total and synaptic expression of the AMPA glutamate receptor GluR2 in vitro and in vivo.
Gray
Neil A
NA
National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA.
Du
Jing
J
Falke
Cynthia S
CS
Yuan
Peixiong
P
Manji
Husseini K
HK
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D018692:Antimanic Agents / Q000494:pharmacology; D015536:Down-Regulation / Q000187:drug effects; D006624:Hippocampus / Q000502:physiology; D007099:Imipramine / Q000494:pharmacology; D007150:Immunohistochemistry; D008094:Lithium / Q000494:pharmacology*; D009924:Organ Culture Techniques; D051381:Rats; D011921:Rats, Inbred WKY; D018091:Receptors, AMPA / Q000096:biosynthesis*; D011956:Receptors, Cell Surface / Q000096:biosynthesis; D013569:Synapses / Q000187:drug effects / Q000378:metabolism*; D014635:Valproic Acid / Q000494:pharmacology
D000928:Antidepressive Agents; D018692:Antimanic Agents; D018091:Receptors, AMPA; D011956:Receptors, Cell Surface; D014635:Valproic Acid; D008094:Lithium; D007099:Imipramine; C104722:glutamate receptor ionotropic, AMPA 2